Gilead: Bad Apple in the Biotech Bunch?
Gilead Sciences is getting killed, but the biotechnology sector seems to be doing just fine. Gilead (GILD) dropped 10% today after it offered up a less rosy outlook than analysts expected. While the biotech juggernaut reported a profit and beat …
Biotech giant Gilead is slipping after revealing its 2017 guidanceBusiness Insider
Don’t Panic: Gilead Sciences Really Isn’t a Value TrapMotley Fool
Biotech Stocks Worth a Closer Look: Gilead Sciences Inc. (NASDAQ:GILD), Ocera Therapeutics, Inc. (NASDAQ:OCRX)The Voice Registrar
all 293 news articles »